Related Experiment Videos
IL-1 receptor type I expression in breast cancer
H Knüpfer1, D Stanitz, M Brauckhoff
1Universität Leipzig, Institut für Klinische Pharmakologie, Härtelstr 16-18, 04107, Leipzig, Germany. popph@server3.medizin.uni-leipzig.de
Breast (Edinburgh, Scotland)
|February 18, 2004
Summary
Breast tumors express the interleukin-1 receptor type I (IL-1RI), suggesting IL-1 signaling promotes tumor growth and metastasis. This receptor is crucial for IL-1 to drive angiogenesis and cancer progression.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Interleukin-1 (IL-1) is implicated in tumor angiogenesis and metastasis.
- IL-1 signaling requires its receptor, IL-1 receptor type I (IL-1RI).
- Glioblastoma cells previously shown to express IL-1RI.
Purpose of the Study:
- To investigate IL-1RI expression in breast tumor specimens.
- To determine the potential role of IL-1RI in breast cancer progression.
Main Methods:
- Analysis of 11 breast tumor specimens.
- Reverse transcriptase polymerase chain reaction (RT-PCR) for IL-1RI detection.
Main Results:
- All 11 breast tumor specimens tested positive for IL-1RI expression.
- Consistent IL-1RI presence across all analyzed breast tumors.
Conclusions:
- Breast tumors express IL-1RI, indicating IL-1 signaling is active.
- IL-1RI mediated signaling may drive pro-tumorigenic factors, supporting tumor growth and metastasis.
- Potential for paracrine or autocrine IL-1 signaling in breast cancer progression.